Journal of Biological Chemistry Response to Reviewers
A JBC revision guide for linking biochemical mechanism, controls, quantification, images, checklists, source data, and claims.
Readiness scan
Before you submit to Journal of Biological Chemistry, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
Journal of Biological Chemistry at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 4.1 puts Journal of Biological Chemistry in a visible tier, citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~30-35% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope, borderline fit rarely improves after submission.
- If timeline matters: Journal of Biological Chemistry takes ~8-12 weeks. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
How to use this page well
These pages work best when they behave like tools, not essays. Use the quick structure first, then apply it to the exact journal and manuscript situation.
Question | What to do |
|---|---|
Use this page for | Building a point-by-point response that is easy for reviewers and editors to trust. |
Start with | State the reviewer concern clearly, then pair each response with the exact evidence or revision. |
Common mistake | Sounding defensive or abstract instead of specific about what changed. |
Best next step | Turn the response into a visible checklist or matrix before you finalize the letter. |
Quick answer: A Journal of Biological Chemistry response to reviewers should connect every referee concern to a verifiable biochemical repair. Start with the Associate Editor's controlling issues, then answer every comment. State the action, result, effect on the claim, and exact location. Cite page and line, figure and panel, table, assay, construct, reagent, checklist, source-data file, or Supporting Information item. JBC currently requires a detailed point-by-point account with revised manuscripts and keeps the clean main file free of tracked changes because it may become the Paper in Press version.
Last reviewed: July 13, 2026.
Run the JBC revision readiness scan when the clean file, checklists, and response are ready to compare. The JBC submission guide covers initial scope, while JBC under review and the review-time guide answer status and timing. See the journal profile for venue context.
From our manuscript review practice
In JBC revisions we review, a recurring gap is a pathway or binding mechanism inferred from co-movement plus one inhibitor. The response adds expression data but not orthogonal perturbation, rescue, direct interaction, kinetics, or a discriminating biochemical control.
JBC revision files are part of the scientific audit
Current JBC guidance says a revised manuscript must include a detailed point-by-point listing of how each reviewer comment was addressed and any other changes made. Authors may upload a marked version as Revised Manuscript (with tracked changes). The main file should remain clean because an accepted version can be published directly as a Paper in Press.
JBC also identifies revision-stage checklists:
Study or file | Revision control |
|---|---|
General revised manuscript | JBC submission checklist, when applicable |
MS/proteomics study | Mass Spectral Proteomics Methods and Data Checklist |
Functional genomics study | Functional Genomics Checklist |
Marked manuscript | Optional tracked/highlighted file for evaluation, not publication |
Clean main manuscript | Complete scientific content with no track changes or color markup |
The live guide and Editorial Manager tasks control. A checklist is not a substitute for fixing the underlying experiment or reporting gap.
Convert each comment into a biochemical proof obligation
Reviewer concern | Evidence that can answer it | Incomplete response |
|---|---|---|
Mechanism is indirect | Orthogonal perturbation, rescue, direct assay, pathway order | More expression correlation |
Binding claim is weak | Affinity, stoichiometry, specificity, competition, and controls | One pulldown image |
Enzyme result is undercharacterized | Initial-rate range, kinetic model, replicates, inhibition logic | One endpoint activity value |
Antibody or reagent is uncertain | Validation, orthogonal reagent, knockout control, provenance | Catalog number alone |
Gel or blot is selective | Source images, markers, replicates, quantification, splice disclosure | Cropped representative panel |
Omics claim is broad | Batch handling, multiplicity, accession, code, targeted validation | A longer pathway list |
Name the biochemical uncertainty first. The added experiment should discriminate among explanations, not merely create more data.
Copyable JBC response template
Use construct, reagent, panel, and source-data identifiers that remain stable when pagination changes.
Dear Associate Editor,
Thank you for the opportunity to revise manuscript JBC-2026-0931,
"Allosteric Control of Mitochondrial Enzyme Assembly." Your summary identifies
three controlling issues: direct evidence for the proposed interaction,
quantitative characterization of the activity change, and validation of the
key antibody. We address these first and then respond point by point. Page and
line numbers refer to the clean revised manuscript.
Associate Editor Issue 1: Direct interaction
Response: We added purified-protein binding with a nonbinding mutant and
competition control, then confirm the interface by cross-linking mass
spectrometry. The measured affinity is weaker than inferred originally, so the
abstract now describes a regulated association rather than stable complex
formation. See page 7, lines 5-28; Figure 3A-E; and Source Data 3.
Reviewer 1, Comment 4
"The activity assay uses one substrate concentration and cannot support the
kinetic interpretation."
Response: We agree. We measured initial rates over the stated substrate range,
fit prespecified competitive and mixed models, and report parameter estimates
with confidence intervals. The data support mixed inhibition, and the Results
and model diagram have been corrected. See Table 2 and page 10, lines 3-27.
Reviewer 2, Comment 2
"The central immunoblot depends on an antibody with unclear specificity."
Response: We added knockout and peptide-block controls, repeat the result with
an independent antibody, provide uncropped source images and molecular-weight
markers, and revise the legend. See Figure 4, Supplemental Figure S5, and
Source Data 4.
Sincerely,
Dr. A. Researcher, on behalf of all authorsIf the result changes direction or magnitude, state that directly. The response is an audit trail, not a sales document.
Build a claim-to-assay map
List every central claim and the minimum evidence chain it needs:
Claim type | Minimum audit trail | Frequent confounder |
|---|---|---|
Protein interaction | Direct/orthogonal assay, specificity, stoichiometry, context | Co-localization or overexpression |
Enzyme regulation | Initial rates, substrate range, model, controls, uncertainty | Endpoint assay outside linear range |
Pathway order | Perturbation, rescue, epistasis, time, alternative pathway | One inhibitor with off-target effects |
Localization mechanism | Quantification, compartment controls, perturbation, function | Representative microscopy field |
Structural explanation | Model quality, validation, interface test, biochemical consequence | Attractive structure without functional test |
Omics mechanism | Prespecified analysis, multiplicity, accession, code, targeted validation | Enrichment result treated as causality |
Use the map to decide whether a reviewer request is essential, helpful, or outside the revised claim. If essential evidence cannot be obtained, narrow the claim and explain the boundary.
Quantitative biochemistry needs more than significance
For kinetic, binding, dose-response, and imaging quantification, make the response recoverable:
- biological and technical replicate definitions;
- raw or transformed scale;
- range chosen and why;
- model and parameter constraints;
- residual or fit diagnostics;
- uncertainty on parameters and contrasts;
- failed or excluded runs with reasons;
- independent validation where appropriate;
- source-data location;
- revised claim language.
A low p-value cannot rescue an assay outside its linear range, an unidentifiable kinetic model, or pseudoreplication across wells and fields.
Image and reagent traceability
JBC's current guide notes that editors may request high-resolution original images, quantification details, antibody validation data, or other material needed to assess technical quality. It also specifies molecular-weight markers for gels and scale bars for microscopy images.
Use a revision table:
Evidence item | Traceability check |
|---|---|
Antibody | Vendor, identifier, lot where relevant, validation, expected and observed band |
Construct | Sequence boundary, tag, mutation, verification, expression context |
Gel/blot | Full source image, markers, loading control, exposure, splice disclosure |
Microscopy | Scale, acquisition, segmentation, field selection, biological unit |
Recombinant protein | Purity, identity, concentration, activity, storage condition |
Dataset | Accession, sample map, batches, processing code, excluded samples |
Do not let the marked manuscript become the only place a reader can reconstruct these details. The clean file and supporting artifacts need to stand alone.
Typography for JBC response letters
Differentiate reviewer comments and author replies with bold labels, boxes, or indentation. Do not rely on color. Separate Associate Editor priorities, referee text, quoted new manuscript text, and author explanation.
Use the marked manuscript to expose changed figures, legends, methods, and claims, but verify that the clean main file contains every accepted scientific change without residual colored text or tracked deletions.
Tone calibration for JBC rebuttals
Avoid | Better |
|---|---|
"The interaction is already clear." | "The submitted pulldown did not establish direct binding. We added purified-protein and competition assays and weakened the complex-stability claim." |
"The enzyme assay is standard." | "The endpoint assay could not identify the kinetic model. We now report initial-rate data, model diagnostics, and parameter uncertainty." |
"The antibody is widely used." | "Use in prior papers does not establish specificity here. Knockout, peptide-block, and independent-antibody controls are now provided." |
"The blot is representative of three experiments." | "All biological replicates, uncropped source images, molecular markers, and the quantified distribution are available in Source Data 4." |
"Pathway enrichment proves activation." | "The enrichment nominates the pathway; targeted perturbation and biochemical readouts support activation in the tested context." |
Push back by explaining what the requested assay can identify and what it cannot. Avoid arguing from convention alone.
In our review work with JBC revisions
In our pre-submission review work with Journal of Biological Chemistry manuscripts, we audit the constructs, reagents, assays, kinetic models, blots and images, source data, omics pipelines, statistical units, checklists, figures, abstract, and mechanistic language. We trace each referee concern from the response into the clean file and source-data package. These are qualitative Manusights patterns, not JBC acceptance statistics or access to confidential reports.
Pattern 1: co-movement becomes direct mechanism
Two proteins change together, co-localize, or appear in the same pulldown, and the manuscript describes direct regulation. The response adds another cell-based association. In Journal of Biological Chemistry revisions, we ask whether direct binding, specificity, pathway order, rescue, and biochemical consequence are actually demonstrated. We see many apparently complete figure additions that still cannot distinguish direct interaction from shared localization or complex membership.
Pattern 2: kinetics are inferred from an endpoint
A single substrate concentration or final signal is used to claim altered affinity, catalytic rate, or inhibition mechanism. For JBC manuscripts, we inspect linear range, depletion, initial rates, model identifiability, parameter uncertainty, and alternative models. The revised claim may be altered activity rather than a specific kinetic mechanism. We audit the raw time course because a well-fitted endpoint model can still rest outside the assay's linear region.
Pattern 3: a validation control repeats the same reagent failure
The response uses another antibody from the same epitope class or another inhibitor with a related off-target profile. We require orthogonal validation: genetic loss, rescue, independent epitope, purified system, or direct analytical measurement.
Pattern 4: omics breadth replaces biochemical closure
The revision adds more differentially expressed features and pathway enrichment but no targeted test of the central mechanism. We link the discovery layer to a discriminating biochemical experiment and keep broad omics findings exploratory when validation is incomplete.
The distinctive JBC information gain is biochemical closure: reagent, assay, quantitative model, source data, and mechanistic sentence must form one inspectable chain.
Check the JBC response, clean manuscript, and evidence files together.
Resolve competing reviewer requests
One reviewer may request more cellular relevance while another asks for purified-system mechanism. Explain how the two layers divide the inference. The purified assay can establish direct biochemical behavior; the cellular experiment can test whether it matters in context. Neither automatically substitutes for the other.
If a requested experiment would require a different article's scope, identify the narrower test of the current claim. Add it or revise the claim. Do not promise future work while retaining present-tense mechanistic certainty.
Rejection risk after a JBC revision
Revision is not acceptance. Most serious rejection-on-revision risks remain when a central mechanism is still indirect, reagents are unvalidated, kinetics are underidentified, images lack source context, omics files or checklists remain incomplete, or the clean manuscript contradicts the tracked response.
Most dangerous is a point-by-point letter that says "addressed" while the new evidence answers a different biochemical question.
Submit if; think twice if
Submit if: every referee point is answered and located; mechanism matches the evidence level; assays are in range and quantitatively identified; reagents and images are traceable; required revision checklists are complete; source data and accessions are usable; and the clean file contains the final science without markup.
Think twice if: direct mechanism still rests on association, a kinetic claim comes from endpoint data, antibody specificity is assumed from prior use, technical fields or wells remain the unit of analysis, or the clean Paper in Press-ready file lacks changes described in the response.
Readiness check
Run the scan while Journal of Biological Chemistry's requirements are in front of you.
See how this manuscript scores against Journal of Biological Chemistry's requirements before you submit.
How this page was reviewed
We reviewed the current JBC guide for authors, revision and resubmission instructions, submission and omics checklist requirements, image and data-reporting guidance, and ASBMB journal materials. We then applied the biochemical proof-obligation audit above. Official sources establish file and checklist rules; the claim-to-assay map is Manusights analysis.
This page does not predict acceptance or replace the Associate Editor's letter and Editorial Manager task list.
Final JBC revision audit
- Put Associate Editor priorities before referee sections.
- Answer every comment and list all other changes.
- Cite page, line, figure, panel, assay, construct, table, checklist, and source data.
- Match mechanistic language to direct and orthogonal evidence.
- Verify assay range, model, statistical unit, and uncertainty.
- Validate antibodies, reagents, constructs, gels, and images.
- Complete general, proteomics, or functional-genomics checklists as applicable.
- Verify accessions, code, source images, and Supporting Information.
- Synchronize response, marked file, clean file, abstract, and conclusion.
- Keep reviewer and author text visually distinct.
Evaluate the owner after 14 finalized GSC days, not from partial reporting. By day 21, use index status, query match, impressions, clicks, CTR, and qualified biochemical-revision starts to keep, improve, combine, or halt the page. JBC's 11,546 cluster impressions and single preview start are selection proxies only.
JBC and ASBMB sources establish revision, checklist, and data requirements. The biochemical closure framework is Manusights interpretation.
Frequently asked questions
Begin with the Associate Editor's controlling scientific and data-reporting issues, then answer every referee comment. State the concern, action, result, changed claim, and exact page, line, figure, panel, table, experiment, checklist, or supporting-information location.
Current JBC guidance requires a detailed point-by-point account of how every reviewer comment was addressed and any other changes. A marked original may be uploaded as Revised Manuscript with tracked changes, while the clean main file should not contain tracked changes or color.
Yes. Current guidance calls for the JBC submission checklist with revised manuscripts when applicable, plus dedicated checklists for mass-spectrometry/proteomics and functional-genomics studies. Follow the live guide and your Editorial Manager task list.
Expect renewed scrutiny of biochemical mechanism, reagent and antibody validation, experimental units, kinetics and dose response, image and gel integrity, omics reporting, source data, computational-model support, and agreement between the response and clean Paper in Press-ready file.
Sources
Final step
Submitting to Journal of Biological Chemistry?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Target journal carried over: Journal of Biological Chemistry
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
- Journal of Biological Chemistry Submission Guide (2026)
- How to Avoid Desk Rejection at Journal of Biological Chemistry
- Journal of Biological Chemistry Review Time: What to Expect
- Rejected from JBC? Choose the Next Journal
- Journal of Biological Chemistry Submission Process: What Happens and What Editors Judge First
- Journal of Biological Chemistry 'Under Review': What Each Status Means